PDF icon PDF herunterladen
Pharmacopsychiatry 1996; 29(2): 79-80
DOI: 10.1055/s-2007-979549
Case Report

© Georg Thieme Verlag Stuttgart · New York

Hepatic Failure Associated with Imipramine Therapy

Y. Ilan1 , D. Samuel2 , M. Reynes3 , Ran Tur-Kaspa1
  • 1Liver unit, Division of Medicine, Hadassah University Hospital, Jerusalem, Israel
  • 2Centre Hepato Biliaire, Hôpital Paul Brousse, Paris, France
  • 3Service d'Anatomie pathologique, Hôpital Paul Brousse, Paris, France
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
23. April 2007 (online)

Auch verfügbar aufeRef
 als PDF herunterladen  Lizenzen und Reprints
Preview

Abstract

Imipramine is an antidepressant drug that is rarely associated with mild liver function abnormalities. These are usually minor and transient liver enzyme elevations which return to normal levels upon discontinuation of the drug. We describe a 48-year-old male who developed subfulminant hepatic failure after imipramine usage, with complete recovery within three months after discontinuation of the drug.